VERTEX PHARMACEUTICALS INC / MA Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 5,000 | 545,700 | 47,500 | |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 220.00 | 5,000 | 1,100,000 | 33,416 | 38.4 K to 33.4 K (-13.02 %) |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 5,000 | 545,700 | 38,416 | 33.4 K to 38.4 K (+14.96 %) |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Option Exercise | M | 187.53 | 4,692 | 879,891 | 20,334 | |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 219.37 | 4,692 | 1,029,284 | 13,098 | 17.8 K to 13.1 K (-26.37 %) |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Buy | M | 187.53 | 4,692 | 879,891 | 17,790 | 13.1 K to 17.8 K (+35.82 %) |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 187.53 | 3,910 | 733,242 | 16,945 | |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 219.37 | 3,910 | 857,737 | 31,553 | 35.5 K to 31.6 K (-11.03 %) |
| Nov 26 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 187.53 | 3,910 | 733,242 | 35,463 | 31.6 K to 35.5 K (+12.39 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 32,502 | 4,286,689 | 0 | |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 64,032 | 6,988,452 | 0 | |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 212.75 | 10,615 | 2,258,341 | 106,346 | 117 K to 106.3 K (-9.08 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 211.43 | 23,033 | 4,869,867 | 116,961 | 140 K to 117 K (-16.45 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.41 | 62,886 | 13,231,843 | 139,994 | 202.9 K to 140 K (-31.00 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 32,502 | 4,286,689 | 202,880 | 170.4 K to 202.9 K (+19.08 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 64,032 | 6,988,452 | 170,378 | 106.3 K to 170.4 K (+60.21 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 5,000 | 545,700 | 52,500 | |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 215.00 | 5,000 | 1,075,000 | 33,416 | 38.4 K to 33.4 K (-13.02 %) |
| Nov 21 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 5,000 | 545,700 | 38,416 | 33.4 K to 38.4 K (+14.96 %) |
| Nov 20 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Gift | G | 0.00 | 239 | 0 | 3,885 | 4.1 K to 3.9 K (-5.80 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 205.95 | 5 | 1,030 | 7,252 | 7.3 K to 7.3 K (-0.07 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 205.95 | 57 | 11,739 | 33,416 | 33.5 K to 33.4 K (-0.17 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 1,493 | 196,912 | 32,502 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 2,941 | 320,981 | 64,032 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 131.89 | 1,683 | 221,971 | 33,995 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 109.14 | 3,317 | 362,017 | 66,973 | |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 1,493 | 313,530 | 106,346 | 107.8 K to 106.3 K (-1.38 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 1,493 | 196,912 | 107,839 | 106.3 K to 107.8 K (+1.40 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 2,941 | 617,610 | 106,346 | 109.3 K to 106.3 K (-2.69 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 2,941 | 320,981 | 109,287 | 106.3 K to 109.3 K (+2.77 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 1,683 | 353,430 | 106,346 | 108 K to 106.3 K (-1.56 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 131.89 | 1,683 | 221,971 | 108,029 | 106.3 K to 108 K (+1.58 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 210.00 | 3,317 | 696,570 | 106,346 | 109.7 K to 106.3 K (-3.02 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 109.14 | 3,317 | 362,017 | 109,663 | 106.3 K to 109.7 K (+3.12 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 205.95 | 61 | 12,563 | 13,098 | 13.2 K to 13.1 K (-0.46 %) |
| Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 205.95 | 60 | 12,357 | 31,553 | 31.6 K to 31.6 K (-0.19 %) |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 155.57 | 2,853 | 443,841 | 3,669 | |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 205.59 | 2,853 | 586,548 | 7,252 | 10.1 K to 7.3 K (-28.23 %) |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 155.57 | 2,853 | 443,841 | 10,105 | 7.3 K to 10.1 K (+39.34 %) |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 155.57 | 4,892 | 761,048 | 11,006 | |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 205.50 | 4,892 | 1,005,306 | 35,003 | 39.9 K to 35 K (-12.26 %) |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 155.57 | 4,892 | 761,048 | 39,895 | 35 K to 39.9 K (+13.98 %) |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 155.57 | 8,560 | 1,331,679 | 11,006 | |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 205.57 | 8,560 | 1,759,679 | 33,240 | 41.8 K to 33.2 K (-20.48 %) |
| Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 155.57 | 8,560 | 1,331,679 | 41,800 | 33.2 K to 41.8 K (+25.75 %) |
| Nov 13 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Option Exercise | M | 155.57 | 509 | 79,185 | 4,587 | |
| Nov 13 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 199.00 | 509 | 101,291 | 13,098 | 13.6 K to 13.1 K (-3.74 %) |
| Nov 13 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Buy | M | 155.57 | 509 | 79,185 | 13,607 | 13.1 K to 13.6 K (+3.89 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 1,223 | 190,262 | 11,006 | |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 1,223 | 190,262 | 11,006 | |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.90 | 210 | 41,559 | 31,553 | 31.8 K to 31.6 K (-0.66 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.90 | 210 | 41,559 | 31,553 | 31.8 K to 31.6 K (-0.66 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.38 | 770 | 151,983 | 31,763 | 32.5 K to 31.8 K (-2.37 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.38 | 770 | 151,983 | 31,763 | 32.5 K to 31.8 K (-2.37 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 196.08 | 243 | 47,647 | 32,533 | 32.8 K to 32.5 K (-0.74 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 196.08 | 243 | 47,647 | 32,533 | 32.8 K to 32.5 K (-0.74 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 1,223 | 190,262 | 32,776 | 31.6 K to 32.8 K (+3.88 %) |
| Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 1,223 | 190,262 | 32,776 | 31.6 K to 32.8 K (+3.88 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,942 | 168,022 | 9,708 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 2,156 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 201.10 | 1,100 | 221,210 | 33,416 | 34.5 K to 33.4 K (-3.19 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 200.12 | 2,497 | 499,700 | 34,516 | 37 K to 34.5 K (-6.75 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 199.77 | 500 | 99,885 | 37,013 | 37.5 K to 37 K (-1.33 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,942 | 168,022 | 37,513 | 35.6 K to 37.5 K (+5.46 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 91.05 | 2,155 | 196,213 | 35,571 | 33.4 K to 35.6 K (+6.45 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,330 | 201,592 | 11,650 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 201.37 | 600 | 120,822 | 35,003 | 35.6 K to 35 K (-1.69 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 200.20 | 1,730 | 346,346 | 35,603 | 37.3 K to 35.6 K (-4.63 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,330 | 201,592 | 37,333 | 35 K to 37.3 K (+6.66 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 7,767 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 2,156 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 201.62 | 1,553 | 313,116 | 33,240 | 34.8 K to 33.2 K (-4.46 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 34,793 | 33.2 K to 34.8 K (+4.67 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 201.62 | 2,155 | 434,491 | 33,240 | 35.4 K to 33.2 K (-6.09 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 35,395 | 33.2 K to 35.4 K (+6.48 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 11,650 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 91.05 | 1,796 | 163,526 | 1,796 | |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 201.23 | 800 | 160,984 | 31,553 | 32.4 K to 31.6 K (-2.47 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 200.26 | 3,326 | 666,065 | 32,353 | 35.7 K to 32.4 K (-9.32 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 86.52 | 2,330 | 201,592 | 35,679 | 33.3 K to 35.7 K (+6.99 %) |
| Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 91.05 | 1,796 | 163,526 | 33,349 | 31.6 K to 33.3 K (+5.69 %) |
| Nov 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | M | 152.74 | 1,291 | 197,187 | 1,938 | |
| Nov 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 200.00 | 1,291 | 258,200 | 5,249 | 6.5 K to 5.2 K (-19.74 %) |
| Nov 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Buy | M | 152.74 | 1,291 | 197,187 | 6,540 | 5.2 K to 6.5 K (+24.60 %) |